Mitral valve annuloplasty devices are expected to see the highest growth in the region. Increased investments in healthcare ...

Tricuspid regurgitation (TR) is common in patients with atrial functional mitral regurgitation (AFMR) but its impact is not ...

Boston Scientific has led a $175 million funding round for the mitral valve developer 4C Medical, which is currently working ...

Capstan Medical’s robot platform has been used for the first in-human robotic assisted transcatheter mitral valve replacement ...

The US Food and Drug Administration (FDA) has granted approval for Valcare Medical’s investigational device exemption ...

"Today marks a pivotal moment in the evolution of structural heart therapy," Capstan Medical CEO Maggie Nixon said.

Yale operates first the BATMAN procedure in CT, a less invasive heart treatment offering faster recovery and new hope for ...

Tricuspid regurgitation (TR) is common in patients with atrial functional mitral regurgitation (AFMR). However, very few studies have explored its clinical characteristics, determinants, and ...

At first disturbing, the life-long artist says she transformed the images in her mind to something more peaceful.

Capstan Medical, a startup focused on robotic-assisted mitral and tricuspid valve replacement, recently completed its first ...